Published: Monday 8 August 2016
Published in the journal, The Lancet, the findings of the PISCES I study sheds more light on the potential use of stem cell treatment for stroke.
Dr Shamim Quadir, Research Communications Manager at the Stroke Association commented:
“In the UK, someone has a stroke every three and half minutes, and over half of all stroke survivors will be left with a disability. One of the few existing treatments which can limit brain damage caused by stroke is thrombolysis. However, this drug treatment can only be used to treat strokes caused by blood clots and must be administered within the first 4.5 hours after a stroke.
"There is an urgent need for alternative treatments to help prevent the debilitating impact of stroke.
"We welcome the latest, published findings from PISCES I, a small clinical trial which involved injecting neural stem cells into the brains of patients with strokes caused by a blood clot. The findings suggest the procedure was associated with improvements in patients’ mobility and neurological ability, which were maintained two years after treatment.
"We now look forward to the results of the larger and ongoing PISCES II study, which could increase our understanding of the potential benefits of this type of stem cell therapy. Although it’s still early days in stem cell research, these findings add to a growing body of evidence which could potentially lead to life-changing treatments for stroke patients in the future.”